baber/WOPTO huggingface dataset:
Patent AU-1129883-A (AU)
Title: Temperature compensation circuit for light emitting diode
Inventor: WIT BENJAMINO DE
IPC: H05B44/00
Filed: 1983-02-10
Abstract: A bias control circuit for a light-emitting diode having compensation of the light output at changing temperature, in which the light-emitting diode (led) used as temperature sensor is taken up together with a series resistor (R3) in a series circuit to which a fixed supply voltage is applied. A further series circuit of two resistors (R1, R2) having strongly different values is connected parallel across the series resistor (R3) and a differential amplifier (A1) is provided, the one and the other input of which are connected respectively to the junction of the two resistors (R1, R2) and to a setting voltage (Vi), and the output of which is connected to a control means (Tr1) taken up in series with the one series circuit.
Patent AU-1147195-A (AU)
Title: Obsturction detection circuit for sample probe
Inventor: NGUYEN DIHN
IPC: G01R19/165
Filed: 1995-01-31
Abstract: An obstruction detection circuit for detecting an obstruction of a sample probe of an automated sample aspiration/dispensation device and a method for detecting such an obstruction. In one embodiment the obstruction detection circuit includes a pressure sensor measuring the pressure in a fluid conduit connecting a pump and the sample probe orifice. The pressure within the connecting fluid conduit is measured by the pressure sensor shortly after the start of the aspiration or dispensation of a fluid volume by the automated sample aspiration/dispensation device. The pressure within the connecting fluid conduit is again measured after the completion of the aspiration or dispensation, and if the pressure has not returned to a predetermined range within a predetermined amount of time, an error condition is reported. <IMAGE>
Patent AU-1300901-A (AU)
Title: A molding machine por polystyrene elements with mechanical locking system of molds
Inventor: CALZOLARI SERGIO
IPC: B29C33/20
Filed: 2000-10-26
Abstract: A molding machine for polystyrene elements with locking systems of die halves (2, 3) obtained by means of multiple mechanical irreversible screw actuators (4). Each actuator (4) receives motion from a chain drive that rotates the toothed crown (27) and the female screw, driving the shaft (15) into motion by means of its acme thread screw (21). The pin engages on the cam (30) located in the body. The cam profile drives the shaft (15) first into rotation-translation and then into axial translation. Further to these movements, the locking element that is joined to the shaft locks the two die halves (2, 3). Therefore, locking and unlocking of the moving die half (2) is obtained by means of the synchronized motion of a series of kinematic mechanisms that allow for obtaining high closing forces with small controlling forces.
Patent AU-1302788-A (AU)
Title: Human manganese superoxide dismutase (hmn-sod)
Inventor: HECKL KONRAD
IPC: C12N15/53
Filed: 1988-03-11
Abstract: A genetic engineering method for the production of human Mn superoxide dismutase (hMn-SOD), the DNA sequences which code for this enzyme, suitable vectors which contains these DNA sequences and host cells which can express these DNA sequences, as well as the enzyme hMn-SOD itself are described. Proposals for the use of this enzyme are additionally described.
Patent AU-1364397-A (AU)
Title: Device for connecting a longitudinal bar to a pedicle screw
Inventor: AMREIN THOMAS
IPC: A61B17/70
Filed: 1997-01-22
Abstract: A device for connecting a longitudinal bar to a pedicle screw for fixation of the spine includes a body having an axis, an upper end, a lower end, a hole coaxial with the axis, and a through hole positioned perpendicular to the axis. The device also includes a collet chuck slidably disposed within the hole. The collet chuck includes a through hole substantially aligned with the through hole of the body for receiving the longitudinal bar. The collet chuck also includes a chamber defined by elastic tongues for receiving the head of the pedicle screw.
Patent AU-1442301-A (AU)
Title: Method and apparatus for transmitting video and graphics in a compressed form
Inventor: GORDON DONALD F
IPC: H04N7/16
Filed: 2000-10-27
Abstract: A stream recombination apparatus comprising: a packet identifier filter for identifying packets in a transport stream having a particular packet identifier and for mapping said packet identifiers; a demultiplexer for extracting and concatenating packets from a transport stream as identified by said packet identifier filter, where a first plurality of extracted packets comprise a plurality of reference picture slices and a second plurality of extracted packets comprise a plurality of predicted picture slices; and a decoder for decoding the concatenated packets to form an uncompressed video sequence.
Patent AU-1544292-A (AU)
Title: (1-3)-beta -d-glucan assaying agent
IPC: G01N33/579
Filed: 1992-03-13
Abstract: An assaying agent which can assay a (1 -> 3)- beta -D-glucan originating in a fungus present in the bodily fluid, such as blood or urine, rapidly and conveniently with high accuracy, said agent comprising a lysate prepared by bringing a limulus amoebocyte lysate optionally containing dextran into contact with an insoluble carrier based on polyamide or cellulose and being substantially free from an endotoxin-sensitive factor. <IMAGE>
Patent AU-1564788-A (AU)
Title: Shortening compositions containing polyol polyesters
Inventor: GUFFEY TIMOTHY BRUCE
IPC: A23L1/308
Filed: 1988-05-05
Abstract: Disclosed are preferred shortenings made with polyol polyesters. The Solid Fat Content curve and penetration of the shortenings is adjusted to increase smoothness and decrease graininess. Also described are food compositions that have enhanced flavors from the addition of particular sucrose polyesters.
Patent AU-1656000-A (AU)
Title: Hydrophobic epoxide resin system
Inventor: BEISELE CHRISTIAN
IPC: C08K3/22
Filed: 1999-11-29
Abstract: The invention relates to a composition containing (a) an epoxide resin, (b) an OH-terminated polysiloxane, (c) a cyclic polysiloxane and (d) a non-ionic, fluoroaliphatic surface-active reagent. The composition has excellent hydrophobicity properties and can be used as an electrical insulation material.
Patent AU-1664388-A (AU)
Title: Method for surface bonding of ceramic bodies
Inventor: NEWKIRK MARC S
IPC: C04B37/00
Filed: 1988-05-20
Abstract: Two or more ceramic bodies (10,12) are bonded together by oxidizing with a vapor-phase oxidant molten metal obtained from a body of precursor metal (14) to form an oxidation reaction product bond. The oxidation reaction product is formed between adjacent facing, substantially congruent surfaces of the ceramic bodies (10,12) and bridges the surfaces, thus bonding the ceramic bodies (10,12) to each other. Promoters may optionally be used to facilitate formation of the oxidation reaction product.
Patent AU-1709583-A (AU)
Title: Forming and handling sectioned products
Inventor: REGINALD BIGGS DONALD
IPC: A23G9/28
Filed: 1983-06-29
Abstract: A process for handling edible products, comprising laying down a length of edible product on to a takeoff conveyor (1,2,3) and cutting the length into sections, characterised by the use of a line of successive travelling turntables (4,5,6,7) along and on which the length is laid, and by cutting the length into sections between the turntables in a manner which allows relative separation by rotation of the cut sections, and by rotating each turntable (4,5,6,7) carrying a cut section through a defined angle, thereby to present a cut end of the section substantially transversely of the line of the conveyor.
Patent AU-1723595-A (AU)
Title: Lipophilic carrier preparations
Inventor: CARLSSON ANDERS
IPC: A23L35/00
Filed: 1995-02-06
Abstract: PCT No. PCT/SE95/00117 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/20945 PCT Pub. Date Aug. 10, 1995The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galacto-lipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetical and food products, as well as to a pharmaceutical composition. The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galactolipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetic and food products, as well as to a pharmaceutical composition.
Patent AU-1848192-A (AU)
Title: Deep oxidation and/or hydrolysis of halogenated organics with porous carbonaceous materials
IPC: A62D101/20
Filed: 1992-06-23
Abstract: A method is provided for oxidising and/or hydrolysing halogenated organic compounds comprising contacting a mixture of the halogenated organic compound, excess oxygen, and-, optionally, water, with a carbonaceous catalyst under mild reaction conditions. The temperature of the reaction is typically below 400 DEG C and the catalyst may be doped with acidic redox-active metal compounds.
Patent AU-2002788-A (AU)
Title: Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
IPC: C07K16/20
Filed: 1988-07-26
Abstract: Toxoplasma gondii (TG) antigens consisting of excretion-secretion (ES) antigens common to the tachyzoites and the bradyzoites of TG, and translation products of mRNA of tachyzoites carrying the epitopes recognised by the abovementioned ES antigens. Polyclonal and monoclonal antibodies capable of conferring significant protection against toxoplasmosis, in the form of vaccines in particular. Therapeutic composition for the treatment of toxoplasmosis, the active constituents of which are the abovementioned ES antigens. Products for the diagnosis of toxoplasmosis, the active constituents of which are the abovementioned ES antigens.
Patent AU-2049000-A (AU)
Title: Process for production of wood composites using a mixed PMDI/solid novolac resin binder
Inventor: ROSTHAUSER JAMES W
IPC: C08L97/02
Filed: 1999-12-10
Abstract: This invention relates to a process for the production of composite wood products. This process comprises a) applying a binder composition to wood particles, and b) molding or compressing the wood particles treated with the binder to form a composite wood product. Suitable binder compositions comprise a polymethylene poly(phenyl isocyanate) and a solid novolac resin.
Patent AU-2082295-A (AU)
Title: Arrangements for transmitting and receiving digital video signals
Inventor: ROSENGREN JURGEN FRITZ
IPC: H04N1/00
Filed: 1995-04-10
Abstract: The invention relates to a method and arrangement for deriving an ancillary signal from a compressed digital video signal (e.g. MPEG). The DC coefficients of autonomously encoded pictures (I-pictures) are selected from the compressed signal. The ancillary signal thus obtained can be used for display in a (multi-) picture-in-picture television receiver. A decoder for decoding such an ancillary signal is considerably simpler and less expensive than a full-spec MPEG decoder.
Patent AU-2094501-A (AU)
Title: Methods for preparing pharmaceutical formulations
Inventor: FLOYD ALISON G
IPC: A61K47/02
Filed: 2000-12-13
Abstract: The invention relates to pharmaceutical formulations and methods for preparing pharmaceutical formulations of histamine releasers. The present invention provides methods for determining the concentration of physiologically acceptable excipient for use in the formulations of invention. The present invention also provides methods for suppressing pharmaceutically-induced histamine release by administering to an animal, the formulations of the present invention. A kit useful for preparing pharmaceutical formulations of histamine releasers is also provided.
Patent AU-2187083-A (AU)
Title: Determination of n-carbamoylsarcosine using n-carbamoyl- sarcosine-amidohydrolase
Inventor: DEEG ROLF
IPC: C12N9/80
Filed: 1983-12-01
Abstract: The present invention provides a process for the determination of N-carbamoylsarcosine, wherein a sample solution containing N-carbamoylsarcosine is reacted with N-carbamoylsarcosine-amidohydrolase to give sarcosine, which is then determined. The present invention also provides the enzyme N-carbamoylsarcosine-amidohydrolase, a process for obtaining it and a reagent containing it.
Patent AU-2227397-A (AU)
Title: Apparatus for measuring a.c. current in a cable
Inventor: MCCORMACK MICHAEL
IPC: G01R1/22
Filed: 1997-02-14
Abstract: An apparatus for measuring an a.c. current flowing in an electric cable comprises a pair of jaws for receiving the cable and which are movable towards one another to engage the opposite sides of the cable. A potentiometer generates a signal ("cable size signal") corresponding to the relative positions of the jaws. A set of coils is provided adjacent the jaws to detect the magnetic field generated by current flowing in the cable. A circuit in the housing is responsive to the cable size signal and the voltage induced in the coil for determining the amplitude of the current flowing in the cable and displaying the same on a display.
Patent AU-2227688-A (AU)
Title: Sulfonamido derivative inhibiting the aldose reductase enzyme system and pharmaceutical compositions containing them
Inventor: CACCIA GIULIO
IPC: A61P25/02
Filed: 1988-09-15
Abstract: The xantosulfonamido and benzensulfonamido derivatives corresponding to the formula: <CHEM> wherein X represents an alkyl-alkoxy halogen, Y represents an alkyl-alkoxy-halogen and Z represents the group <CHEM>  or Y and Z taken together form the group: <CHEM> wherein R1 in turn is a group selected among electron attracting groups, halogens and the group: <CHEM> possess activity in inhibiting the aldose-reductase enzyme system and are thus useful in the treatment of the complications , at the eye and peripheral neuropathy levels, as induced by diabetes.
Patent AU-2252395-A (AU)
Title: Suspended storage apparatus
Inventor: WALSER HANS HEIRI
IPC: B65G1/06
Filed: 1995-05-02
Abstract: PCT No. PCT/CH95/00095 Sec. 371 Date Feb. 9, 1996 Sec. 102(e) Date Feb. 9, 1996 PCT Filed May 2, 1995 PCT Pub. No. WO95/29861 PCT Pub. Date Nov. 9, 1995An apparatus particularly suitable for the suspended storage of foodstuffs in any available space, comprising a frame consisting of at least one basic module (30) with four vertical posts (31a, 31b, 31c, 31d) joined together in pairs by upper (35) and lower (34) longitudinal coupling members and upper (37) and lower (36) transverse coupling members. The lower ends of the posts comprise four lower connecting members (32a, 32b, 32c, 32d) and four upper connecting members (33a, 33b, 33c, 33d), the connecting members being provided with coupling devices for mounting horizontally or vertically adjacent modules.
Patent AU-2316188-A (AU)
Title: Process for preparation of organic chemicals
Inventor: GODTFREDSEN SVEN ERIK
IPC: C12R1/40
Filed: 1988-08-17
Abstract: Process for the racemization of an amino acid amide with the general Formula I <CHEM> the amino acid amide being brought into contact with an enzyme with amino acid amide racemase activity. In particular the invention relates to a process for enzymatic preparation of optically active amino acids from amino acid amides by bringing the amino acid amide into contact with a biocatalyst which in addition possesses L- or D-amidase activity.
Patent AU-2321102-A (AU)
Title: Off-board navigation system with personalized navigation database
Inventor: UPPARAPALLI KARUNANIDHI
IPC: G08G1/0968
Filed: 2002-03-08
Abstract: An off-board navigation system includes a remote unit and a supply location. In operation, a navigation system user requests a desired route to a destination. Capability information relating to the user's CPU and storage device capacities are also preferably provided to the supply location. Using the extensive database available at the supply location, the supply location calculates a recommended route to the desired destination in relation to the desired POIs. If the estimated size of the requested route meets the capabilities of the remote unit the supply location creates a filter using the requested parameters and applied to the extensive database at the supply location. In one embodiment, the filtered map area includes a width vector W defined substantially perpendicular to the recommended route R. In another embodiment, the filtered map area is defined in relation to a plurality of nodes N along the recommended route R. A perimeter P is defined around each node N along the recommended route R. Moreover, the type of road can be adjusted to meet the capability information relating to the user's CPU and storage device. <IMAGE>
Patent AU-2429399-A (AU)
Title: Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction
Inventor: GORNY PHILIPPE
IPC: A61K31/445
Filed: 1999-02-12
Abstract: The invention concerns the association of an antagonist of α-adrenergic receptors, for instance yohimbine, and a nitrogen monoxide donor, for instance arginine, with synergistic effect and useful for fighting against female sexual dysfunction.
Patent AU-2462395-A (AU)
Title: High activity catalysts
Inventor: SHUKIS PETER JOSEPH
IPC: C10G47/02
Filed: 1995-05-01
Abstract: Provided is a process for improving the activity of catalysts based upon gamma alumina containing substrates impregnated with one or more catalytically active metals.
Patent AU-2661099-A (AU)
Title: Dengue viruses that are replication defective in mosquitos for use as vaccines
Inventor: ZENG LINGLING
IPC: C07K14/18
Filed: 1999-02-05
Abstract: The present invention is directed toward vector stage replication-defective flaviviruses that are replication-defective in mosquisto vectors that transmit them to human. Such mutant flaviviruses may be useful as vaccines. The replication-defective flaviviruses of the present invention demonstrate a limited ability to replicate in the vector organisms that transmit flaviviruses from one host to another. More specifically, the present invention is directed toward the construction and propagation of flaviviruses that possess 3'-noncoding regions altered in such a way as to prevent or severely limit viral reproduction in a vector organism. In one embodiment of the present invention, a replication-defective dengue virus that is replication-defective in arthropods is contemplated for use as a vaccine. In another embodiment, a replication-defective dengue virus that is replication-defective in mosquitos is contemplated for use as a vaccine. The present invention also contemplates methods of producing such mutant flaviviruses for use as vaccines as well as methods that induce a protective immunity against flavivirus infection or disease in an immunized subject.
Patent AU-2726184-A (AU)
Title: N-pyrazin-2-ylphosporamidates
Inventor: HOPWOOD WILLIAM JOHN
IPC: A01N57/32
Filed: 1984-04-26
Abstract: Novel pyrazine compounds having general formula <CHEM> wherein X represents oxygen or sulphur; R represents a hydrogen or a metal atom or an ammonium, aryl or lower alkyl group; and Y represents an optionaliy substituted aromatic or heteroaromatic group, have useful herbicidal properties.
Patent AU-2748295-A (AU)
Title: Tie strips
Inventor: HARSLEY ANDREW JOHN
IPC: B65D63/10
Filed: 1995-06-23
Abstract: PCT No. PCT/GB95/01487 Sec. 371 Date Mar. 3, 1997 Sec. 102(e) Date Mar. 3, 1997 PCT Filed Jun. 23, 1995 PCT Pub. No. WO96/00176 PCT Pub. Date Jan. 4, 1996An integrally formed tie strip (10) is formed with a series of apertures (14), at respective locations that are spaced apart in succession along the strip, and is formed with a series of laterally projecting latch members (11), at respective locations that are spaced apart in succession along the strip, for resisting withdrawal from one of the said apertures after having been passed therethrough.
Patent AU-2778900-A (AU)
Title: Improved animal chew
Inventor: AXELROD GLEN
IPC: A23K1/14
Filed: 2000-04-14
Abstract: An animal chew 10 which is made from molded fruit chips 12. In a second embodiment, an animal chew which is made from a molded thermoplastic resin having fruit chips dispersed therein. In a third embodiment, an animal chew which is made from starch having fruit chips dispersed therein. <IMAGE>
Patent AU-2875799-A (AU)
Title: Tumor tissue microarrays for rapid molecular profiling
Inventor: LEIGHTON STEPHEN B
IPC: G01N33/566
Filed: 1999-02-24
Abstract: An array-based technology facilitates rapid correlated gene copy number and expression profiling of a very large numbers of human tumors. Hundreds of cylindrical tissue biopsies (diameter 0.6 mm) from morphologically representative regions of individual tumors can be arrayed in a single paraffin block. Consecutive sections from such arrays provide targets for parallel in situ visualization and quantitation of DNA, RNA or protein targets. For example, amplifications of six loci (mybL2, erbB2, Cyelin-D1, riryc, 17q23 and 20q13) were rapidly determined by fluorescence in situ hybridization from 372 ethanol-fixed breast cancers. Stratifcation of tumors by estrogen receptor and p53 expression data revealed distinct patterns of gene amplification in the various subgroups of breast cancer that may have prognostic utility. The tissue array technology is useful in the rapid molecular profiling of hundreds of normal and pathological tissue specimens or cultured cells.
Patent AU-2884592-A (AU)
Title: Treatment of neurological conditions by an interleukin-1 inhibiting compound
IPC: A61P25/28
Filed: 1992-11-02
Abstract: PCT No. PCT/GB92/02023 Sec. 371 Date Jul. 29, 1994 Sec. 102(e) Date Jul. 29, 1994 PCT Filed Nov. 2, 1992 PCT Pub. No. WO93/08820 PCT Pub. Date May 13, 1993The use of a compound which prevents, inhibits or modifies the action of interleukin-1 as an active agent for the treatment of conditions of neurological degeneration. The active agent may be IL-1 receptor antagonist, particularly recombinant IL-1 ra.
Patent AU-2922797-A (AU)
Title: Novel steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
Inventor: TJOENG FOE S
IPC: C07J71/00
Filed: 1997-04-28
Abstract: The present invention relates to a pharmaceutical composition or preparation which comprises hydroxyl containing steroidal hormones and organic nitrite/nitrate or other nitric oxide donating agents.
Patent AU-2923600-A (AU)
Title: Addressing bistable nematic liquid crystal devices
Inventor: HUGHES JONATHAN RENNIE
IPC: G09G3/36
Filed: 2000-03-02
Abstract: A bistable nematic liquid crystal device is addressed by application of a row waveform to successive row electrodes of an x, y matrix of pixels whilst one of two data waveforms are applied to each column electrode. The row waveform has a period of two or more time slots (ts), with two dc pulses of opposite amplitude for causing a switching to a dark state, and two dc pulses of opposite amplitude for causing a switching to a light state. The data waveforms have the same period as the strobe with dc pulses of opposite amplitude and combine with the strobe pulses to switch the device. The device can be addressed in two field periods, one field switching to a dark state, the other field switching to a light state. Alternatively, the device can be blanked to the dark state then selectively switched to the light state. When blanking is used, the row waveform has blanking de pulses placed a short time before selective switching to reduce overall addressing time. Zero voltage pulses may be used within the two or more time slot period of the strobe and data waveforms; these reduce rms. voltages appearing at the pixels and enhance contrast ratio.